NEWS: Jefferies analyst, Glen Santangelo, lowers $HIMS price target to $15 from $17, downgrading from buy to hold.
This signals a 19% upside from today’s valuation.
The firm's decision comes amid considerations of market concerns that have persisted since the company's IPO.
These concerns include the barriers to entry in the market, the sustainability of growth, pricing strategies, & the effectiveness of marketing expenditures.